Xylem (XYL) Research & Development (2010 - 2026)

Xylem has reported Research & Development for 17 years, with the latest figure at $59.0 million in Q2 2026.

• On a quarterly basis, Research & Development rose 1.72% year-over-year to $59.0 million in Q2 2026; TTM through Jun 2026 was $227.0 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $226.0 million, down 1.74% from the prior year.
• Research & Development was $59.0 million for Q2 2026 at Xylem, up from $56.0 million in the prior quarter.
• The five-year high for Research & Development was $61.0 million in Q3 2023, with the low at $47.0 million in Q3 2022.
• Average Research & Development over 5 years is $56.1 million, with a median of $57.0 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Research & Development gained 29.79% in 2023, then dropped 9.84% in 2024.
• Over 5 years, Research & Development stood at $54.0 million in 2022, then advanced by 11.11% to $60.0 million in 2023, then decreased by 3.33% to $58.0 million in 2024, then rose by 3.45% to $60.0 million in 2025, then decreased by 1.67% to $59.0 million in 2026.
• The last three Research & Development figures came in at $59.0 million (Q2 2026), $56.0 million (Q1 2026), and $60.0 million (Q4 2025), per Business Quant data.